Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

v3.22.4
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
$ in Thousands
Total
Conversion of Convertible Debt
Common Stock
Common Stock
Conversion of Convertible Debt
Additional Paid-in Capital
Additional Paid-in Capital
Conversion of Convertible Debt
Stockholders’ Accumulated Deficit
Balances, at Beginning of period at Dec. 31, 2020 $ (26,695)   $ 3   $ 54,097   $ (80,795)
Balances, at Beginning of period (in shares) at Dec. 31, 2020     32,949,507        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Exercise of common warrants 646       646    
Exercise of common warrants (in shares)     69,232        
Issuance of Series C redeemable convertible preferred stock and common stock issued for commitment shares 14,068       14,068    
Issuance of Series C redeemable convertible preferred stock and common stock issued for commitment shares (in shares)     1,756,525        
Issuance of common stock warrants 433       433    
Business Combination and PIPE Financing 109,805   $ 4   109,801    
Business Combination and PIPE Financing (in shares)     37,843,390        
Warrants issued in connection with the Convertible Note 14,522       14,522    
Exercise of stock options 575   $ 1   574    
Exercise of stock options (in shares)     1,282,820        
Vesting of restricted stock units, net of taxes (in shares)     105,780        
Stock—based compensation expense 2,538       2,538    
Conversion of convertible notes payable   $ 10,089       $ 10,089  
Conversion of convertible notes payable (in shares)       1,055,388      
Net loss (100,769)           (100,769)
Balances, at End of period at Dec. 31, 2021 25,212   $ 8   206,768   (181,564)
Balances, at End of period (in shares) at Dec. 31, 2021     75,062,642        
Increase (Decrease) in Stockholders' Equity [Roll Forward]              
Issuance of Series C redeemable convertible preferred stock and common stock issued for commitment shares 851       851    
Issuance of Series C redeemable convertible preferred stock and common stock issued for commitment shares (in shares)     299,491        
Exercise of stock options $ 151   $ 0   151    
Exercise of stock options (in shares) 770,635   770,635        
Vesting of restricted stock units, net of taxes $ (115)       (115)    
Vesting of restricted stock units, net of taxes (in shares)     433,940        
Stock—based compensation expense 5,151       5,151    
Conversion of convertible notes payable   $ 8,138 $ 1     $ 8,137  
Conversion of convertible notes payable (in shares)       13,276,430      
Net loss 15,170           15,170
Balances, at End of period at Dec. 31, 2022 $ 54,558   $ 9   $ 220,943   $ (166,394)
Balances, at End of period (in shares) at Dec. 31, 2022     89,843,138